Does Calidi Biotherapeutics (CLDI) Pay a Dividend? (2026)
Short answer
Calidi Biotherapeutics (CLDI) pays little or no dividend; like many growth-oriented companies it reinvests cash rather than paying income. A dividend is a slice of profits returned to shareholders, and the yield is that payout divided by the share price, so it drifts as both change. Figures here are approximate; verify the current number with your broker.
Does Calidi Biotherapeutics (CLDI) pay a dividend?
Calidi Biotherapeutics (CLDI) currently returns little or nothing as a dividend. A pre-revenue clinical biotech like Calidi cannot be valued on earnings, because there are none; metrics like P/E are not meaningful. Investors who study these companies typically weigh the cash runway against the quarterly burn rate, the timing and probability of upcoming clinical catalysts (such as trial starts, data readouts, and FDA designations), and the dilution required to fund the next stage of development. For Calidi specifically, the very low cash balance, going-concern doubt, reverse split, and heavy warrant overhang mean financing risk and dilution are central to any assessment, and the stock can swing dramatically on capital raises as much as on science.
How to think about CLDI's dividend
- Yield is a snapshot: minimal today, but it moves with price and payout.
- Total return vs income: dividends are one part of return; price change is usually the bigger part for a name like CLDI.
- Reinvest or take income: a DRIP compounds; taking the cash gives income now.
- For more yield: dedicated dividend stocks and ETFs target higher payouts. See the best dividend ETFs.
The bottom line on the CLDI dividend
Calidi Biotherapeutics (CLDI) is not an income stock; if you own it, it is for growth or total return, not the dividend. For the full picture see the CLDI guide. Walnut can show how CLDI fits your real portfolio. It is not an investment adviser.
Build a basket around CLDI with Walnut
Use Calidi Biotherapeutics as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
Does Calidi Biotherapeutics (CLDI) pay a dividend?
+
Calidi Biotherapeutics (CLDI) pays little or no dividend; like many growth-stage companies it tends to reinvest cash rather than return it as income. Verify the current policy on CLDI's investor relations page.
What is CLDI's dividend yield?
+
CLDI's yield is minimal or zero. Companies prioritizing growth often pay no dividend and return cash through buybacks instead, if at all.
How often does CLDI pay its dividend?
+
US companies that pay dividends, like Calidi Biotherapeutics if it does, typically distribute them quarterly. Confirm the exact schedule and ex-dividend dates on CLDI's investor relations page before relying on the timing.
Can I reinvest CLDI dividends?
+
Yes. Most brokers offer automatic dividend reinvestment (a DRIP) so any CLDI dividend buys more shares automatically. It compounds over time but is still taxable in a taxable account.
Is CLDI a good dividend stock?
+
Walnut is informational, not investment advice. CLDI is a growth or total-return name rather than an income stock. Dedicated dividend stocks and ETFs target higher, steadier yield; match the choice to whether you want income now or growth.
Does CLDI pay a dividend?
+
No. Calidi Biotherapeutics does not pay a dividend. It is a pre-revenue, clinical-stage company that is unprofitable and burns cash, so it directs all available capital toward research and operations rather than returning money to shareholders. Any potential return from CLDI would have to come from share-price appreciation, not income, and the company's limited cash makes a dividend highly unlikely for the foreseeable future.
Walnut is informational, not investment advice. Dividend figures are approximate and dated; verify current yield, schedule, and policy with CLDI's investor relations page or your broker.